Sigyn Therapeutics
Sigyn Therapeutics is developing medical devices to treat cancer and infectious disease disorders, with a focus on extracorporeal blood purification. Their innovative platforms include ImmunePrep, ChemoPrep, and ChemoPure, with Sigyn Therapy as their lead candidate targeting infectious diseases not treatable with drugs. The company aims to provide strategic value to the pharmaceutical, dialysis, and organ transplant industries, driven by a passionate team of industry experts and inventors.
Industries
Nr. of Employees
small (1-50)
Products
Adjunct extracorporeal platform for antibody-based immunotherapy
A blood purification platform intended to be used with antibody therapeutics to improve targeted delivery and therapeutic performance.
Adjunct extracorporeal platform to improve chemotherapy delivery
A platform intended to improve delivery of chemotherapeutic agents to tumors and reduce systemic exposure during treatment.
Extracorporeal blood purification to reduce post-chemotherapy toxicity
An extracorporeal approach intended to remove or reduce toxic species after chemotherapy to diminish treatment-related toxicity.
Extracorporeal blood purification for pathogen-associated inflammatory disorders
An extracorporeal therapy intended to address infectious-disease-related conditions and pathogen-associated inflammation that are not directly treatable with drugs.
Adjunct extracorporeal platform for antibody-based immunotherapy
A blood purification platform intended to be used with antibody therapeutics to improve targeted delivery and therapeutic performance.
Adjunct extracorporeal platform to improve chemotherapy delivery
A platform intended to improve delivery of chemotherapeutic agents to tumors and reduce systemic exposure during treatment.
Extracorporeal blood purification to reduce post-chemotherapy toxicity
An extracorporeal approach intended to remove or reduce toxic species after chemotherapy to diminish treatment-related toxicity.
Extracorporeal blood purification for pathogen-associated inflammatory disorders
An extracorporeal therapy intended to address infectious-disease-related conditions and pathogen-associated inflammation that are not directly treatable with drugs.
Services
Clinical study management for extracorporeal device studies
Operational design, investigator contracting, and oversight of human clinical studies for extracorporeal therapies.
Clinical study management for extracorporeal device studies
Operational design, investigator contracting, and oversight of human clinical studies for extracorporeal therapies.
Expertise Areas
- Extracorporeal blood purification
- Clinical trial management for medical devices
- Medical device engineering and product development
- Regulatory strategy and device submissions
Key Technologies
- Extracorporeal blood filtration and adsorption
- Blood-contacting cartridges and membrane technologies
- Exosome capture and blood-based biomarker analysis
- Adjunct extracorporeal platforms for immunotherapy and chemotherapy